This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
RBS Q4 op profit £572m, net profit £286m (rebound YoY but down QoQ), final divi 3.5p+7.5p special takes FY yield to 5.3%; No extra PPI provision; Q4 net interest margin +2bp, FY -15bp; 2020 sub-50% Cost-to-Income target (Q4 80%, FY 72%) is challenging; pol/geopol uncertainty could up 2019 credit losses, increasing impairments; Op expenses to fall but strategic costs +50% to £1.5bn
Mondi ups FY guidance before 28 Feb results, expecting underlying EPS +25-29%.
Segro plans to raise £450m via share placing to fund development pipeline. FY adj. pre-tax profit +24.4%, portfolio value +10.7%, ERPA NAV/share +16.9%, net borrowing +11.4%, loan-to-value -10bps to 29%, FY div +13.3%. Secured 75% of £46m rent expected to be generated in 2019 from projects under construction. Plans 2019 capex -12.7%.
Centamin reports Côte d’Ivoire drilling programme resulted in a doubling of mineral resource (Indicated gold resource +55%) and budgeted another drilling programme for 2019.
Millennium & Copthorne Hotels FY like-for-like total revenue +1% (Q4: +1.1%), Hotel rev. +0.6% (Q4: +2.6%), RevPAR +0.7% (Q4: +3.9%), pre-tax profit -26.4% (Q4: -76.7%). Final div -51% to 2.15p. Expects another challenging year in 2019 with significant capital projects underway.
(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
| Stock | Close | High | Low |
| Rolls Royce | 0.8% | 2.0% | 0.4% |
| AstraZeneca | 7.5% | 8.2% | 2.2% |
| PaddyPower Betfair | -2.3% | 0.1% | -2.4% |
| Micro Focus | 12.3% | 15.0% | 3.3% |
| Coca-Cola HBC | -8.6% | -3.4% | -8.6% |
| Convatec | -18.9% | -13.6% | -23.6% |
| Indivior | -1.0% | 8.8% | -4.7% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.
Prepared by Michael van Dulken, Head of Research